Keyphrases
Epidermal Growth Factor Receptor
100%
Glioblastoma
100%
Bispecific Antibody
100%
Anti-CD3
100%
Cytokine-induced Killer Cells
100%
U87MG
22%
Tumor
11%
Progression-free Survival
11%
Clinical Application
11%
U87 Cells
11%
Cytotoxic Activity
11%
Interleukin-2
11%
Cell Support
11%
Cytolytic Activity
11%
Effector Target
11%
Glioblastoma multiforme
11%
Bioluminescent
11%
Luciferase Reporter Assay
11%
Anti-EGFR
11%
Surface Molecules
11%
In Vivo Antitumor Activity
11%
Xenograft Mice
11%
Proliferation Ability
11%
Glioblastoma Xenografts
11%
Adjuvant Immunotherapy
11%
Expression Ability
11%
Cytokine-induced Killer
11%
Immunology and Microbiology
Epidermal Growth Factor
100%
Bispecific Antibody
100%
Cytokine Induced Killer Cell
100%
CD3 Antigen
100%
In Vitro
100%
Immunotherapy
22%
Cytokine
11%
Tumor Necrosis Factor
11%
Interleukin 2
11%
Xenograft
11%
Survival Rate
11%
Cytotoxicity
11%
Progression Free Survival
11%
Bioluminescence
11%